Antiplatelet drugs and intraoperative haemorrhage;Antiplaquettaires et hémorragie peropératoire

Revue Medicale Suisse

Volumn 2, Issue 88, 2006, Pages 2684-2687

  Chassot, Pierre Guy ^a   Delabays, Alain ^a   Ravussin, Patrick ^b   Spahn, Donat R ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CHCVs   (Switzerland)

^c Neurologische Poliklinik USZ   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; TICLOPIDINE;

BLEEDING; BLOOD CLOTTING; BRAIN SURGERY; CORONARY ARTERY THROMBOSIS; HUMAN; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; ALGORITHM; DRUG ANTAGONISM; DRUG COMBINATION; INTRAOPERATIVE PERIOD; PATHOPHYSIOLOGY;

ALGORITHMS; ASPIRIN; BLOOD LOSS, SURGICAL; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; HUMANS; INTRAOPERATIVE PERIOD; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RISK ASSESSMENT; TICLOPIDINE;

EID: 33845877698     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Le Manach Y, Perrel A, Coriat P, et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005;102:885-91.
2. Dawood MM, Gupta DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: Implications regarding physiopathology and prevention. Int J Cardiol 1996;57:37-44.
3. Giroud D, Li JM, Urban P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992;69:729-32.
4. Blake GJ, Ridker PM. Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002;252:283-94.
5. Popma JJ, Berger P, Ohman EM, et al. Antithrombotic therapy during percutaneous coronary intervention: The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004;126(Suppl. 3):576S-99.
6. Serruys PW, Kutryk MJB, Ong ATL. Coronary artery stents. N Engl J Med 2006;354:483-95.
7. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-33.
8. Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
9. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-63.
10. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
11. Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The CHARISMA trial. N Engl J Med 2006;354:1706-17.
12. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-94.
13. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: When is it safe to operate? Catheter Cardiovasc Interv 2004;63:141-5.
14. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-40.
15. ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery - executive summary. Circulation 2002;105:1257-67.
16. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndrome. Circulation 2004;110:2361-7.
17. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 2006;113:2803-9.
18. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
19. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9.
20. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Int Med 2005;257:399-414.
21. Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: A 5-year survey and identification of avoidable risk factors. Neurosurgery 1994;35:1061-4.
22. Steinbuhl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized trial (CREDO). JAMA 2002;288:2411-20.
23. Michlig C, Vu DH, Wasserfallen JB, et al. Three years of haemovigilance in a general university hospital. Transfus Med 2003;13:63-72.
24. Chu MWA, Wilson SR, Novick RJ, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-41.
25. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995;80:303-9.
26. Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: A randomized, controlled veteran affairs cooperative study. Ann Surg 2001;234:560-9.